Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/18/1998 | EP0878549A2 Process for the enzymatic production of fructosylated compounds |
11/18/1998 | EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor |
11/18/1998 | EP0878491A2 Heparin analogues homo- or copolymers, their preparation and their use |
11/18/1998 | EP0878480A1 A method for the improvement of neuronal regeneration |
11/18/1998 | EP0878479A2 G-protein coupled receptor (HOFNH30) |
11/18/1998 | EP0878467A1 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids |
11/18/1998 | EP0878463A1 Excitatory amino acid receptor modulators |
11/18/1998 | EP0878198A1 Tablets containing anion exchange resin |
11/18/1998 | EP0878196A1 Kainic acid neuronotoxicity inhibitors and pyridothiazine derivatives |
11/18/1998 | EP0878195A1 Use of a 2-aroyl-3-arylbenzo(b)thiophene compound for reducing fibrinogen |
11/18/1998 | EP0878193A1 Remedies for herpesvirus infection caused by herpesvirus and preventives for recurrence of the infection both containing triterpene derivatives as the active ingredient |
11/18/1998 | EP0878192A2 Method for treating protozoal infections |
11/18/1998 | EP0878191A2 Stable aqueous solution containing selegiline and device for its administration |
11/18/1998 | EP0877943A1 Methods for measurement and treatment predicated on the presence of advanced glycosylation endproducts in tobacco and its combustion byproducts |
11/18/1998 | EP0877809A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
11/18/1998 | EP0877807A1 Biologically active and particularly peptide molecules having a potentiating effect on growth hormone biological activity |
11/18/1998 | EP0877806A1 Nucleotide sequences that encode phosphatidylinositol-3' kinase associated proteins and uses thereof |
11/18/1998 | EP0877804A1 Inhibitors of cell-cycle progression, and uses related thereto |
11/18/1998 | EP0877803A1 Ob protein receptor and related compositions and methods |
11/18/1998 | EP0877802A1 NEUROGENIC DIFFERENTIATION (NeuroD) GENES AND PROTEINS |
11/18/1998 | EP0877796A1 Compositions and methods for mediating cell cycle progression |
11/18/1998 | EP0877795A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
11/18/1998 | EP0877759A1 Methods for increasing endogenous levels of corticotropin-releasing factor |
11/18/1998 | EP0877755A1 Two-component signal transduction response regulator polypeptides from staphylococcus aureus |
11/18/1998 | EP0877750A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents |
11/18/1998 | EP0877748A1 Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use |
11/18/1998 | EP0877747A1 Azaspiro derivatives with 5ht 1b? activity |
11/18/1998 | EP0877744A1 Substituted aza- and diazacycloheptane and cyclooctane compounds and their use |
11/18/1998 | EP0877743A1 ((3"-thioxacyclohex-1"-enyl))-but-3'-ene-1'-ynyl)aryl and heteroaryl carboxylic acids and esters having retinoid-like biological activity |
11/18/1998 | EP0877740A1 Thiol derivatives with metallopeptidase inhibitory activity |
11/18/1998 | EP0877739A1 Azole compounds endowed with antimycotic activity for human and veterinary use |
11/18/1998 | EP0877737A1 Novel n-(arylsulphonyl)amino acid derivatives having bradykinin receptor affinity |
11/18/1998 | EP0877735A1 Polycyclic compounds |
11/18/1998 | EP0877734A1 Quinoline and quinazoline compounds useful in therapy |
11/18/1998 | EP0877733A1 Process for production of piperidine derivatives |
11/18/1998 | EP0877627A1 Obesity protein analog compounds and formulations thereof |
11/18/1998 | EP0877625A1 Immunomodulatory methods using oligosaccharides |
11/18/1998 | EP0877623A1 Intranasal vaccination against gastrointestinal disease |
11/18/1998 | EP0877621A1 Combined pharmaceutical preparation containing lhrh-analogous substances and anti-estrogens for treating gynaecological disorders |
11/18/1998 | EP0877620A1 Peptides for altering osteoblast adhesion |
11/18/1998 | EP0877619A1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract |
11/18/1998 | EP0877617A1 Composition for treating cancer containing a ribose compound, beta-alanine, ascorbic acid and nicotinic acid |
11/18/1998 | EP0877616A1 Medicaments containing aromatic azo compounds |
11/18/1998 | EP0877615A1 Combination therapy method for treating cancer using edatrexate and a taxane derivative, e.g. paclitaxel |
11/18/1998 | EP0877614A1 Method for inducing death of neoplastic cells using piperazine oxirane derivatives |
11/18/1998 | EP0877613A2 Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients |
11/18/1998 | EP0877612A1 Use of piperazine derivatives for the treatment of cognitive disorders |
11/18/1998 | EP0877611A1 Hemoregulatory compounds |
11/18/1998 | EP0877610A1 Inhibitors of farnesyl-protein transferase |
11/18/1998 | EP0877609A1 Formulation for respiratory tract administration |
11/18/1998 | EP0877608A1 SENSITIZATION OF HER2/neu OVER-EXPRESSING CANCER CELLS TO CHEMOTHERAPEUTIC DRUGS |
11/18/1998 | EP0877607A1 Biphenyl compounds and use thereof as oestrogenic agents |
11/18/1998 | EP0877606A1 Effervescent ibuprofen preparation and process for the production thereof |
11/18/1998 | EP0877605A2 Solid instant-release forms of administration and process for producing the same |
11/18/1998 | EP0877601A1 Combination injection preparation |
11/18/1998 | EP0877598A1 Anthelmintic paste |
11/18/1998 | EP0877563A1 Food and vitamin preparations containing the natural isomer of reduced folates |
11/18/1998 | EP0877555A1 Method of inhibiting immune system destruction of transplanted viable cells |
11/18/1998 | EP0877554A1 Triterpene derivatives with immunosuppressant activity |
11/18/1998 | EP0757669B1 O-acyl-4-phenyl-cyclohexanols, their salts, medicaments containing such compounds and their use, as well as a method of preparing them |
11/18/1998 | EP0749304B1 Slow-release tablet containing diclofenac-na |
11/18/1998 | EP0732935B1 Lyophilized stem cell factor formulations |
11/18/1998 | EP0724581B1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
11/18/1998 | EP0713386B1 Spray formulation having a cooling effect |
11/18/1998 | EP0706514B1 Compounds and methods for inhibition of hiv and related viruses |
11/18/1998 | EP0697821B1 Cholesterol lowering drink mix compositions |
11/18/1998 | EP0688312B1 New derivatives of glutamic acid, a method of preparing them, and their use as drugs for enhancing memory and learning |
11/18/1998 | EP0573498B1 Aliphatic propargylamines as selective mao-b inhibitors and as neuroprotective agents |
11/18/1998 | EP0551501B1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
11/18/1998 | EP0537201B1 1-[4-(imidazol-1-yl)benzoyl]piperidine derivatives as antiarrhythmic agents |
11/18/1998 | CN1199426A Antigenic preparations |
11/18/1998 | CN1199403A 5-0-deosaminyl 6-0-methyl erythronolide A dirivs., preparation method therefor and use thereof for preparing biologically active materials |
11/18/1998 | CN1199400A 8-azabicycle [3.2.1]oct-2-ene derivs, their preparation and use |
11/18/1998 | CN1199399A Naphthamide derivs, of 3-beta-amino azabicyclo octane or nonane as neuroleptic agents |
11/18/1998 | CN1199398A 1-[2-(2,3-dihydro-1H-inden-1-yl) ethyl]-4-(naphthalen-1-yl) piperazine derivs, preparation thereof and therapeutical use thereof |
11/18/1998 | CN1199397A Pyrimidin derivatives |
11/18/1998 | CN1199396A Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
11/18/1998 | CN1199395A Process for preparation of anti-malarial drugs |
11/18/1998 | CN1199394A Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing same |
11/18/1998 | CN1199339A Aqueous eye drops contg. apafant as principal agent |
11/18/1998 | CN1199338A Novel fused isoquinolines as dopamine receptor ligands |
11/18/1998 | CN1199337A Method of inhibiting plasminogen activator inhibitor 1 |
11/18/1998 | CN1199336A Method to increase retinal blood flow |
11/18/1998 | CN1199335A Pharmaceutical preparation contg. nimesulide for topical use |
11/18/1998 | CN1199050A Method for preparation of mother-of-pearl glycosaminoglycan |
11/18/1998 | CN1199048A New compound and its derivatives and their use |
11/18/1998 | CN1199045A Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids |
11/18/1998 | CN1199044A New compound and its derivatives and their use |
11/18/1998 | CN1198936A Chinese and Western medicine capsule for curing psoriasis and leucodermia in sleep |
11/18/1998 | CN1198930A Carmustinum powder injection and its preparation method |
11/18/1998 | CN1198929A Composition comprising tramadol material and acetaminophen and its use |
11/18/1998 | CN1040759C Carbo-acyclic nucleoside derivs. as antiviral and antineoplastic agents |
11/18/1998 | CN1040758C Process for preparation of crystalline fumarate of diazabiscyclic nonane |
11/18/1998 | CN1040756C Heterocyclic compounds preparation process |
11/18/1998 | CN1040755C Heterocyclic compounds production process |
11/18/1998 | CN1040753C Pyridine derivs. and preparation process thereof |
11/18/1998 | CN1040748C Benzazepine deriv., pharmaceutical composition contg. same, and intermediate for same |
11/18/1998 | CN1040747C N-substituent-4-substd. phenyl-5-alkyl-5-substd. benzyl-pyrrolidone-2, its intermediate, and its synthetic method and use |
11/18/1998 | CN1040746C New crystalline form of vitamin D analogue |
11/18/1998 | CN1040718C Method for treatment of disease of shrimp |